GlassScriptPhysician profile
Brett Kathmann
NPI 1851666150
$3,848.90
in general payments reported to CMS, 2019-2025
18 companies · $882 in 2025
The $882 reported for 2025 was more than what 95% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2021: $460 · 2022: $1,038 · 2023: $518 · 2024: $779 · 2025: $882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,179.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $3,051.78 | 2019-2025 | Puraply, Novachor, Affinity |
| Kerecis Limited | $171.66 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Convatec INC. | $102.42 | 2021-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.17 | 2022 | |
| Cardiovascular Systems INC. | $59.34 | 2019 | |
| Reprise Biomedical, INC. | $45.71 | 2024 | Miro3d |
| Solventum Corporation | $43.60 | 2024-2025 | V.A.C. Granufoam, Activ.A.C. |
| Ossur Americas, INC. | $39.69 | 2025 | |
| Misonix INC | $38.97 | 2021 | |
| Janssen Pharmaceuticals, INC | $35.69 | 2019-2023 | Xarelto |
| Smith+Nephew, INC. | $33.92 | 2022-2023 | Renasys Go V2 Home, Pico 7 |
| Molnlycke Health Care US, LLC | $26.74 | 2023 | Mepilex Border Sacrum, Exufiber, Mepilex |
| Abbvie INC. | $22.96 | 2024 | |
| Urgo Medical North America, LLC | $20.75 | 2024 | Urgok2 |
| Kci USA, INC. | $20.58 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrofera LLC | $16.41 | 2023 | Hydrofera Blue |
| Astrazeneca Pharmaceuticals LP | $11.68 | 2022 | |
| Melinta Therapeutics, LLC | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Kathmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.